DSIP

DSIP is a synthetic nonapeptide studied in non-human research models in relation to hypothalamic neuroregulatory signaling, corticotropin release modulation, and sleep-associated peptide pathway behavior. Scientific literature examines this compound in the context of neuroendocrine axis activity, stress-response peptide signaling, and CNS neuropeptide behavior under varied experimental conditions in controlled non-human research environments.

Research applications commonly explored in the literature include:

Hypothalamic neuroregulatory peptide signaling and sleep-associated pathway investigation in non-human models

Corticotropin and stress-axis peptide modulation research in neuroendocrine frameworks

Delta-wave sleep peptide behavior and circadian-associated signaling pathway studies

Comparative neuropeptide activity studies alongside related CNS-active peptide analogues

Neuropeptide metabolic stability and receptor interaction modeling in controlled laboratory settings

The lyophilized vial format allows researchers to evaluate compound stability, reconstitution characteristics, and handling parameters within controlled laboratory settings, supporting consistency across experimental preparation. Each DSIP 5 mg vial from KÖLD is prepared and filled in the United States under sterile laboratory conditions. All batches are verified by independent third-party laboratories for purity, volume accuracy, and molecular identity.

1. What is DSIP studied for in research settings?
DSIP appears in scientific literature in relation to hypothalamic neuroregulatory signaling, corticotropin release modulation, and sleep-associated peptide pathway behavior. Research models investigate its activity within neuroendocrine axis frameworks and stress-response peptide signaling in non-human systems.

2. What is the structural classification of DSIP?
DSIP is a synthetic nonapeptide — a nine amino acid sequence — originally identified in hypothalamic research. It is structurally distinct from hormones, steroids, and growth factors, and is classified within the neuropeptide research compound category.

3. How does DSIP relate to other CNS-active peptides studied in neuroregulatory research?
DSIP appears alongside compounds such as Selank and Semax in scientific literature examining overlapping neuroregulatory and hypothalamic peptide signaling pathways. Each compound operates through distinct receptor interactions and signaling mechanisms, making comparative multi-peptide study designs a common framework in CNS neuropeptide research.

4. Is DSIP approved for any use in humans or animals?
No. DSIP is not approved for human or veterinary use. All products sold by KÖLD are strictly for in vitro and non-human laboratory research purposes only.

5. How is purity and quality verified?
Each DSIP 5 mg vial undergoes independent third-party laboratory testing to confirm molecular identity, purity, and volume accuracy prior to release.

Before Reconstitution

Store sealed vial in a freezer at -20°C (–4°F)

Keep away from light and humidity

After Reconstitution

Store at 4°C (39°F)

Use within 14 days

Avoid repeated freeze-thaw cycles

This compound is supplied as a lyophilized powder.
Use KÖLD Solution (sterile, lab-grade solvent) if your protocol requires reconstitution.
Reconstitute only when ready to begin your study.
For research use only. Not for human or animal use.
Not intended to diagnose, treat, cure, or prevent any disease.